ICD-10-CM Billable Code

I70.535

Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of other part of foot

Clinical Classification Guidelines

Inclusion Terms

  • Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of toe

Medical Intelligence & Overview

Atherosclerosis of nonautologous biological bypass grafts of the right leg with foot ulceration is a condition involving the build-up of fatty deposits in the blood vessels of a surgically bypassed blood vessel, leading to narrowed or blocked arteries. This can impair blood flow and cause ulcerations, especially in the toes or other parts of the foot. Proper understanding of this condition can help in managing symptoms and preventing complications.

Causes & Symptoms

Clinical Causes: Progressive accumulation of cholesterol and fatty materials within blood vessel walls (atherosclerosis). Previous vascular surgeries involving bypass grafts using nonautologous biological tissues, such as synthetic or donor tissue grafts. Chronic conditions like high blood pressure and high cholesterol levels contribute to vessel narrowing. Smoking and lifestyle factors that accelerate artery damage. Diabetes mellitus, which impairs blood flow and increases the risk of ulcers and infections.

Key Symptoms: Ulcerations on the toes or other parts of the foot, often painful or slow-healing. Discoloration or pallor of the affected toes or foot. Swelling or inflammation around ulcer sites. Pain or discomfort in the leg, especially during activity or walking. Reduced or absent pulses in the affected limb. Coldness or numbness in the foot or toes. Signs of infection such as redness, warmth, or pus in ulcer areas.

Diagnostic & Treatment

Diagnosis Path: Doppler ultrasound to assess blood flow in the affected arteries. Ankle-brachial index (ABI) measurement to compare blood pressure in the ankles versus the arms. Angiography (X-ray with contrast) to visualize blood vessel blockages or narrowing. Physical examination focusing on pulses, skin condition, and ulcer characteristics. Laboratory tests to evaluate blood cholesterol and glucose levels.

Treatment Protocols: Lifestyle modifications such as smoking cessation, healthy diet, and regular exercise under medical guidance. Medications to control cholesterol, blood pressure, and blood sugar levels. Wound care for foot ulcers, including cleaning, dressing, and infection control. Medications to improve blood flow, such as antiplatelet agents. Surgical or endovascular procedures to restore arterial blood flow, including angioplasty or bypass surgery. In some cases, amputation may be necessary if the ulcer becomes severely infected or gangrenous.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is I70.535 a billable ICD-10 code?
Yes, I70.535 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report I70.535?
Clinical documentation must specify the nature of Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of other part of foot and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

nonautologous biological atherosclerosis ulceration bypass